OGN
No price yet
Announcements
Nothing here yet
Daily updates
Nothing here yet
FDA designations
Nothing here yet
News
- Organon Canada announces approval and availability of NDUVRA (tapinarof cream) 1%, a steroid-free topical treatment for moderate to severe atopic dermatitis in adults and children aged 2 and olderSep 28, 2026
- Organon's supplemental NDA for the hormone-free MIUDELLA intrauterine device was accepted for FDA review in the U.S.Sep 14, 2026
- Phase 3 pooled analysis shows Organon’s VTAMA cream delivers early and consistent improvements in atopic dermatitisJul 24, 2026
- Organon received FDA approval to expand indications for TOFIDENCE in cytokine release syndrome and pediatric COVID-19Jun 10, 2026
- The European Commission approved POHERDY as the first biosimilar to PERJETA in EuropeApr 30, 2026